Skip to content

Effect of continuous and biphasic positive airway pressure in patients with Covid

Comparison of the effect of continuous positive airway pressure )CPAP) and biphasic Positive Airway Pressure (BiPAP) on hemodynamic parameters in covid-19 patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210424051061N1
Enrollment
46
Registered
2021-09-29
Start date
2021-05-05
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: In this research, the CPAP device of Saadat and venet manufacturers is used. Using an air pump, the CPAP device transmits airflow to the patient at a pressure set b
Adjustable pressure range: 20 - 4 cm water
Pressure adjustment: 3 - 0 cm of water
Adjustable initial pressure by the patient
Device settings with buttons
LED lights on the device
Storing, calculating and retrieving information is like the average total treatment hours. Intervention 2: Intervention group: In this research, the BIPAP device of Fisher and Resmed manufacturers is

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor
Vice Chancellor for Research, Gonabad University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Age 20 -60 y/o No history of cardiovascular disease such as hypertension, liver, kidney according to self-declaration Need to prescribe oxygen and candidate for non-invasive respiratory assistance (NIV) according to physician (no need for intubation) No ban on the use of masks Definitive diagnosis of coronavirus infection by physician and laboratory results

Exclusion criteria

Exclusion criteria: Need to intubate the patient immediately Awareness level based on the Glasgow scale less than 15 Any change in the patient's condition that affects the course of treatment, for example blood pressure below 90 mmhg despite fluid therapy or the use of vasopressors

Design outcomes

Primary

MeasureTime frame
Mean score of hemodynamic parameters. Timepoint: Before the mask is prescribed, it will be examined by a person immediately after use and after 1 hour, 6 hours and then daily for up to 3 days at a specific time. Method of measurement: Patient-connected monitoring device.

Secondary

MeasureTime frame
Mean oxygen saturation, mean blood pressure, mean pulse rate. Timepoint: Based on the monitor attached to the patient before the mask is administered, immediately after use and after 1 hour, 6 hours and then daily for up to 3 days at a specific time will be examined by one person. Method of measurement: Patient-connected monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Kokab Basiri Moghaddam

Gonabad University of Medical Sciences

k.basiri@gmu.ac.ir+98 51 5722 3513

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026